Literature DB >> 21647761

Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database.

Richard L White1, Gregory D Ayers, Virginia H Stell, Shouluan Ding, Jeffrey E Gershenwald, Jonathan C Salo, Barbara A Pockaj, Richard Essner, Mark Faries, Kim James Charney, Eli Avisar, Axel Hauschild, Friederike Egberts, Bruce J Averbook, Carlos A Garberoglio, John T Vetto, Merrick I Ross, David Chu, Vijay Trisal, Harald Hoekstra, Eric Whitman, Harold J Wanebo, Daniel Debonis, Michael Vezeridis, Aaron Chevinsky, Mohammed Kashani-Sabet, Yu Shyr, Lynne Berry, Zhiguo Zhao, Seng-Jaw Soong, Stanley P L Leong.   

Abstract

BACKGROUND: Numerous predictive factors for cutaneous melanoma metastases to sentinel lymph nodes have been identified; however, few have been found to be reproducibly significant. This study investigated the significance of factors for predicting regional nodal disease in cutaneous melanoma using a large multicenter database.
METHODS: Seventeen institutions submitted retrospective and prospective data on 3463 patients undergoing sentinel lymph node (SLN) biopsy for primary melanoma. Multiple demographic and tumor factors were analyzed for correlation with a positive SLN. Univariate and multivariate statistical analyses were performed.
RESULTS: Of 3445 analyzable patients, 561 (16.3%) had a positive SLN biopsy. In multivariate analysis of 1526 patients with complete records for 10 variables, increasing Breslow thickness, lymphovascular invasion, ulceration, younger age, the absence of regression, and tumor location on the trunk were statistically significant predictors of a positive SLN.
CONCLUSIONS: These results confirm the predictive significance of the well-established variables of Breslow thickness, ulceration, age, and location, as well as consistently reported but less well-established variables such as lymphovascular invasion. In addition, the presence of regression was associated with a lower likelihood of a positive SLN. Consideration of multiple tumor parameters should influence the decision for SLN biopsy and the estimation of nodal metastatic disease risk.

Entities:  

Mesh:

Year:  2011        PMID: 21647761      PMCID: PMC3461951          DOI: 10.1245/s10434-011-1826-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  45 in total

1.  Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma.

Authors:  K M McMasters; S L Wong; M J Edwards; M I Ross; C Chao; R D Noyes; V Viar; P B Cerrito; D S Reintgen
Journal:  Surgery       Date:  2001-08       Impact factor: 3.982

2.  Factors associated with response to high-dose interleukin-2 in patients with metastatic melanoma.

Authors:  G Q Phan; P Attia; S M Steinberg; D E White; S A Rosenberg
Journal:  J Clin Oncol       Date:  2001-08-01       Impact factor: 44.544

3.  Significance of multiple nodal basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy.

Authors:  G A Porter; M I Ross; R S Berman; J E Lee; P F Mansfield; J E Gershenwald
Journal:  Ann Surg Oncol       Date:  2000-05       Impact factor: 5.344

4.  Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma.

Authors:  J D Wagner; M S Gordon; T Y Chuang; J J Coleman; J T Hayes; S H Jung; C Love
Journal:  Cancer       Date:  2000-07-15       Impact factor: 6.860

5.  Identification of histological features associated with metastatic potential in thin (<1.0 mm) cutaneous melanoma with metastases. A study on behalf of the EORTC Melanoma Group.

Authors:  Martin G Cook; Alain Spatz; Eva-Bettina Bröcker; Dirk J Ruiter
Journal:  J Pathol       Date:  2002-06       Impact factor: 7.996

6.  Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases.

Authors:  Joan Guitart; Lori Lowe; Michael Piepkorn; Victor G Prieto; Michael S Rabkin; Salve G Ronan; Christopher R Shea; Victor A Tron; Wain White; Raymond L Barnhill
Journal:  Arch Dermatol       Date:  2002-05

7.  Significance of dual-basin drainage in patients with truncal melanoma undergoing sentinel lymph node biopsy.

Authors:  Ira A Jacobs; C K Chang; George I Salti
Journal:  J Am Acad Dermatol       Date:  2003-10       Impact factor: 11.527

Review 8.  Selective sentinel lymphadenectomy for malignant melanoma.

Authors:  Stanley P L Leong
Journal:  Surg Clin North Am       Date:  2003-02       Impact factor: 2.741

9.  Should tumor mitotic rate and patient age, as well as tumor thickness, be used to select melanoma patients for sentinel node biopsy?

Authors:  John F Thompson; Helen M Shaw
Journal:  Ann Surg Oncol       Date:  2004-03       Impact factor: 5.344

10.  Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients.

Authors:  Dennis L Rousseau; Merrick I Ross; Marcella M Johnson; Victor G Prieto; Jeffrey E Lee; Paul F Mansfield; Jeffrey E Gershenwald
Journal:  Ann Surg Oncol       Date:  2003-06       Impact factor: 5.344

View more
  24 in total

1.  Sentinel Lymph Node Biopsy Is Prognostic in Thickest Melanoma Cases and Should Be Performed for Thick Melanomas.

Authors:  Dale Han; Gang Han; Monica T Duque; Steven Morrison; Stanley P Leong; Mohammed Kashani-Sabet; John Vetto; Richard White; Schlomo Schneebaum; Barbara Pockaj; Nicola Mozzillo; Vernon K Sondak; Jonathan S Zager
Journal:  Ann Surg Oncol       Date:  2020-06-10       Impact factor: 5.344

2.  Reply: The significance of regression in thin melanoma of the skin.

Authors:  K M Joyce; P J Regan
Journal:  Ir J Med Sci       Date:  2017-05-06       Impact factor: 1.568

3.  Immune response in melanoma: an in-depth analysis of the primary tumor and corresponding sentinel lymph node.

Authors:  Michelle W Ma; Ratna C Medicherla; Meng Qian; Eleazar Vega-Saenz de Miera; Erica B Friedman; Russell S Berman; Richard L Shapiro; Anna C Pavlick; Patrick A Ott; Nina Bhardwaj; Yongzhao Shao; Iman Osman; Farbod Darvishian
Journal:  Mod Pathol       Date:  2012-03-16       Impact factor: 7.842

Review 4.  Clinical utilities and biological characteristics of melanoma sentinel lymph nodes.

Authors:  Dale Han; Daniel C Thomas; Jonathan S Zager; Barbara Pockaj; Richard L White; Stanley Pl Leong
Journal:  World J Clin Oncol       Date:  2016-04-10

Review 5.  Progression of cutaneous melanoma: implications for treatment.

Authors:  Stanley P L Leong; Martin C Mihm; George F Murphy; Dave S B Hoon; Mohammed Kashani-Sabet; Sanjiv S Agarwala; Jonathan S Zager; Axel Hauschild; Vernon K Sondak; Valerie Guild; John M Kirkwood
Journal:  Clin Exp Metastasis       Date:  2012-08-15       Impact factor: 5.150

6.  Stratifying SLN incidence in intermediate thickness melanoma patients.

Authors:  James M Chang; Heidi E Kosiorek; Amylou C Dueck; Stanley P L Leong; John T Vetto; Richard L White; Eli Avisar; Vernon K Sondak; Jane L Messina; Jonathan S Zager; Carlos Garberoglio; Mohammed Kashani-Sabet; Barbara A Pockaj
Journal:  Am J Surg       Date:  2017-12-14       Impact factor: 2.565

7.  Sentinel node biopsy is indicated for thin melanomas ≥0.76 mm.

Authors:  Dale Han; Daohai Yu; Xiuhua Zhao; Suroosh S Marzban; Jane L Messina; Ricardo J Gonzalez; C Wayne Cruse; Amod A Sarnaik; Christopher Puleo; Vernon K Sondak; Jonathan S Zager
Journal:  Ann Surg Oncol       Date:  2012-07-06       Impact factor: 5.344

8.  Validation of a nomogram predicting sentinel lymph node status in melanoma in an Irish population.

Authors:  J F C Woods; J A De Marchi; A J Lowery; A D K Hill
Journal:  Ir J Med Sci       Date:  2014-07-06       Impact factor: 1.568

9.  Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial.

Authors:  Sojun Hoshimoto; Tatsushi Shingai; Donald L Morton; Christine Kuo; Mark B Faries; Kelly Chong; David Elashoff; He-Jing Wang; Robert M Elashoff; Dave S B Hoon
Journal:  J Clin Oncol       Date:  2012-09-24       Impact factor: 44.544

10.  Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients.

Authors:  Charles M Balch; John F Thompson; Jeffrey E Gershenwald; Seng-Jaw Soong; Shouluan Ding; Kelly M McMasters; Daniel G Coit; Alexander M M Eggermont; Phyllis A Gimotty; Timothy M Johnson; John M Kirkwood; Stanley P Leong; Merrick I Ross; David R Byrd; Alistair J Cochran; Martin C Mihm; Donald L Morton; Michael B Atkins; Keith T Flaherty; Vernon K Sondak
Journal:  Ann Surg Oncol       Date:  2014-02-15       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.